Maria P. Pistillo
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Association between PD-1 single nucleotide gene variants and the risk of metastatic melanoma.
Journal: Archives of dermatological research
Published: April 02, 2024
The predictive and prognostic role of single nucleotide gene variants of PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors.
Journal: Immuno-oncology technology
Published: January 09, 2024
Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesothelioma (PM): Correlation with Modified RECIST Score.
Journal: Diagnostics (Basel, Switzerland)
Published: August 06, 2021
Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis.
Journal: Journal of cancer research and clinical oncology
Published: July 29, 2020
Phenotypic characterization of tumor CTLA-4 expression in melanoma tissues and its possible role in clinical response to Ipilimumab.
Journal: Clinical immunology (Orlando, Fla.)
Published: October 09, 2019
Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization.
Journal: Cancer immunology, immunotherapy : CII
Published: August 05, 2019
Determination of Mesothelin Levels in Pleural Effusion Does Not Help Predict Survival of Patients With Malignant Pleural Mesothelioma.
Journal: Anticancer research
Published: July 22, 2019
IFN-γ upregulates membranous and soluble PD-L1 in mesothelioma cells: potential implications for the clinical response to PD-1/PD-L1 blockade.
Journal: Cellular & molecular immunology
Published: May 07, 2019
The Correlation of Serum Mesothelin Level With Pleural Thickness in Malignant Pleural Mesothelioma Makes it a Valuable Tool for Monitoring Tumor Progression.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 13, 2018
Immune Checkpoints and Innovative Therapies in Glioblastoma.
Journal: Frontiers in oncology
Published: July 26, 2018
Last Updated: 09/26/2026